BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21897216)

  • 1. Lessons learned from the SYNTAX trial for multivessel and left main stem coronary artery disease.
    Taggart DP
    Curr Opin Cardiol; 2011 Nov; 26(6):502-7. PubMed ID: 21897216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease. Insights from the SYNTAX run-in phase.
    Kappetein AP; Dawkins KD; Mohr FW; Morice MC; Mack MJ; Russell ME; Pomar J; Serruys PW
    Eur J Cardiothorac Surg; 2006 Apr; 29(4):486-91. PubMed ID: 16497510
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery (SYNTAX) study: design, rationale, and run-in phase.
    Ong AT; Serruys PW; Mohr FW; Morice MC; Kappetein AP; Holmes DR; Mack MJ; van den Brand M; Morel MA; van Es GA; Kleijne J; Koglin J; Russell ME
    Am Heart J; 2006 Jun; 151(6):1194-204. PubMed ID: 16781219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes in patients with de novo left main disease treated with either percutaneous coronary intervention using paclitaxel-eluting stents or coronary artery bypass graft treatment in the Synergy Between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery (SYNTAX) trial.
    Morice MC; Serruys PW; Kappetein AP; Feldman TE; Ståhle E; Colombo A; Mack MJ; Holmes DR; Torracca L; van Es GA; Leadley K; Dawkins KD; Mohr F
    Circulation; 2010 Jun; 121(24):2645-53. PubMed ID: 20530001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.
    Banning AP; Westaby S; Morice MC; Kappetein AP; Mohr FW; Berti S; Glauber M; Kellett MA; Kramer RS; Leadley K; Dawkins KD; Serruys PW
    J Am Coll Cardiol; 2010 Mar; 55(11):1067-75. PubMed ID: 20079596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictive accuracy of SYNTAX score for predicting long-term outcomes of unprotected left main coronary artery revascularization.
    Chakravarty T; Buch MH; Naik H; White AJ; Doctor N; Schapira J; Mirocha JM; Fontana G; Forrester JS; Makkar R
    Am J Cardiol; 2011 Feb; 107(3):360-6. PubMed ID: 21256999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [3-year results of the SYNTAX trial--stent or surgery? A surgeon's perspective].
    Conradi L; Reichenspurner H
    Clin Res Cardiol Suppl; 2011 May; 6():43-8. PubMed ID: 22528177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of completeness of revascularization on the five-year outcome in percutaneous coronary intervention and coronary artery bypass graft patients (from the ARTS-II study).
    Sarno G; Garg S; Onuma Y; Gutiérrez-Chico JL; van den Brand MJ; Rensing BJ; Morel MA; Serruys PW;
    Am J Cardiol; 2010 Nov; 106(10):1369-75. PubMed ID: 21059423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial.
    Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ
    J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stenting versus surgical bypass grafting for coronary artery disease: systematic overview and meta-analysis of randomized trials.
    Biondi-Zoccai GG; Abbate A; Agostoni P; Parisi Q; Turri M; Anselmi M; Vassanelli C; Zardini P; Biasucci LM
    Ital Heart J; 2003 Apr; 4(4):271-80. PubMed ID: 12784781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of bypass surgery and stenting for the treatment of multivessel disease: results from the ARTS trial in Israel.
    Gruberg L; Milo S; Ben Tzvi M; Lotan C; Merin G; Braun S; Mohr R; Tzivoni D; Bitran D; Beyar R;
    Isr Med Assoc J; 2003 Aug; 5(8):539-42. PubMed ID: 12929288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization of left main coronary artery disease.
    Lee MS; Faxon DP
    Cardiol Rev; 2011; 19(4):177-83. PubMed ID: 21646871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary artery bypass graft surgery (CABG) for patients with diabetes and multivessel coronary artery disease: identifying patients who would benefit with CABG and understanding the potential mechanisms involved.
    Greason KL; Schaff HV
    Coron Artery Dis; 2010 Nov; 21(7):402-6. PubMed ID: 20706113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Percutaneous coronary intervention with stent implantation versus coronary artery bypass surgery for treatment of left main coronary artery disease: is it time to change guidelines?
    Park SJ; Park DW
    Circ Cardiovasc Interv; 2009 Feb; 2(1):59-68. PubMed ID: 20031694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management and outcome of patients with established coronary artery disease: the Euro Heart Survey on coronary revascularization.
    Lenzen MJ; Boersma E; Bertrand ME; Maier W; Moris C; Piscione F; Sechtem U; Stahle E; Widimsky P; de Jaegere P; Scholte op Reimer WJ; Mercado N; Wijns W;
    Eur Heart J; 2005 Jun; 26(12):1169-79. PubMed ID: 15802360
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug-eluting stents for interventional revascularization of coronary multivessel disease.
    Ong AT; van der Giessen WJ
    J Interv Cardiol; 2005 Dec; 18(6):447-53. PubMed ID: 16336425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balancing benefit against risk in the choice of therapy for coronary artery disease. Lesson from prospective, randomized, clinical trials of percutaneous coronary intervention and coronary artery bypass graft surgery.
    Morrison DA; Sacks J
    Minerva Cardioangiol; 2003 Oct; 51(5):585-97. PubMed ID: 14551526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials.
    Daemen J; Boersma E; Flather M; Booth J; Stables R; Rodriguez A; Rodriguez-Granillo G; Hueb WA; Lemos PA; Serruys PW
    Circulation; 2008 Sep; 118(11):1146-54. PubMed ID: 18725490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patients enrolled in coronary intervention trials are not representative of patients in clinical practice: results from the Euro Heart Survey on Coronary Revascularization.
    Hordijk-Trion M; Lenzen M; Wijns W; de Jaegere P; Simoons ML; Scholte op Reimer WJ; Bertrand ME; Mercado N; Boersma E;
    Eur Heart J; 2006 Mar; 27(6):671-8. PubMed ID: 16423872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CABG in 2012: Evidence, practice and the evolution of guidelines.
    Taggart DP
    Glob Cardiol Sci Pract; 2012; 2012(2):21-8. PubMed ID: 24688987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.